Document is current
Any future updates will be listed below
-
Authors
Wagner, Verena
Bousset, Laura https://orcid.org/0000-0002-5339-3173
Ascensão-Ferreira, Mariana https://orcid.org/0000-0002-5247-246X
Sun, Bin https://orcid.org/0000-0002-8963-4100
Barragan Avila, José Efren https://orcid.org/0000-0002-9348-909X
Kaizeler, Alexandre
Martins-Silva, Rita
Rahbari, Mohammad https://orcid.org/0000-0003-1133-2134
Fernández-Vaquero, Mirian https://orcid.org/0000-0002-2781-5643
Haston, Scott https://orcid.org/0000-0003-3928-4808
Tinti, Michele https://orcid.org/0000-0002-0051-017X
Pombo, Joaquim
Khadayate, Sanjay https://orcid.org/0000-0003-4278-6403
Roth, Susanne https://orcid.org/0000-0002-5136-4686
Schürch, Christian M. https://orcid.org/0000-0002-1792-1768
Martínez-Barbera, Juan Pedro https://orcid.org/0000-0002-5292-7276
Bahat, Anat
Wee, Keng Boon
Morton, Jennifer P.
Malek, Nisar https://orcid.org/0000-0002-9916-4608
Innes, Andrew J. https://orcid.org/0000-0003-0918-8882
Vernia, Santiago
Barbosa-Morais, Nuno L. https://orcid.org/0000-0002-1215-0538
Gallage, Suchira https://orcid.org/0000-0002-1956-3597
Heikenwalder, Mathias https://orcid.org/0000-0002-3135-2274
Gil, Jesús https://orcid.org/0000-0002-4303-6260
- License Information
-
More Information
Article History
Received: 24 November 2025
Accepted: 25 March 2026
First Online: 15 April 2026
Competing interests
: J.G. has acted as a consultant for Unity Biotechnology, Geras Bio, Myricx Pharma, and Merck KGaA. Pfizer and Unity Biotechnology have funded research in J.G.’s lab (unrelated to the work presented here). J.G. owns equity in Geras Bio. J.G. is a named inventor in MRC and Imperial College patents, both related to senolytic therapies (the patents are not related to the work presented here). AstraZeneca, Redx Pharma, and UCB Biopharma have funded research in J.P.M.’s lab (unrelated to the work presented here). C.M.S. is a cofounder, shareholder and employee of Vicinity Bio GmbH, and is a scientific advisor to and has received research funding from Enable Medicine Inc., unrelated to the work presented here. J.P.M. has received funding from Avacta and Neobe Therapeutics, unrelated to the work presented here. The remaining authors declare no competing interests.
